All Stories

  1. Community-Onset Fungemias: Epidemiology and Genomic Characterization at a Tertiary-Care Hospital in Barcelona, Spain

    Article • Journal of Fungi, November 2025, MDPI AG

    Dr Ferran Navarro

  2. Community-Onset Fungemias: Epidemiology and Genomic Characterization

    Article • October 2025, MDPI AG

    Dr Ferran Navarro

  3. Spanish nationwide survey of Pseudomonas aeruginosa cefiderocol susceptibility and resistance mechanisms

    Article • International Journal of Antimicrobial Agents, October 2025, Elsevier

    Dr Ferran Navarro

  4. Successful implementation of a bundle to prevent increased excessive-spectrum antimicrobial use under new EUCAST susceptibility definitions: a quasi-experimental study in a tertiary hospital

    Article • Journal of Hospital Infection, July 2025, Elsevier

    Dr Ferran Navarro

  5. In Vitro Immune Response of Mononuclear Cells to Multidrug-Resistant Escherichia coli

    Article • Microorganisms, May 2025, MDPI AG

    Dr Ferran Navarro

  6. Non-tuberculous mycobacteria isolates from patients with chronic pulmonary disease and no epidemiological relationship show sequence clusters through whole-genome sequencing

    Article • Frontiers in Microbiology, March 2025, Frontiers

    Dr Ferran Navarro

  7. Megaprosthesis Infection by Bacteroides fragilis in a Patient With Ewing's Sarcoma: A Case Report and Literature Review

    Article • Clinical Case Reports, February 2025, Wiley

    Dr Ferran Navarro

  8. Considerations to the comments on the recommendations of the Spanish Antibiogram Committee (COESANT) for the preparation of Cumulative Antibiotic Sensitivity Reports

    Article • Enfermedades infecciosas y microbiologia clinica (English ed ), October 2024, Elsevier

    Dr Ferran Navarro

  9. Consideraciones sobre los comentarios a las recomendaciones del Comité Español del Antibiograma (COESANT) para la realización de los informes de sensibilidad antibiótica acumulada

    Article • Enfermedades Infecciosas y Microbiología Clínica, October 2024, Elsevier

    Dr Ferran Navarro

  10. Early identification of the nosocomial spread of vancomycin-resistant Enterococcus faecium by Fourier-transform infrared spectroscopy and performance comparison with PFGE and WGS

    Article • Emerging Microbes & Infections, August 2024, Taylor & Francis

    Dr Ferran Navarro

  11. Megaprosthesis Infection by Bacteroides fragilis in a patient with Ewing’s Sarcoma: a case report and literature review.

    Article • July 2024, Wiley

    Dr Ferran Navarro

  12. Author Correction: Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection

    Article • Scientific Reports, July 2024, Springer Science + Business Media

    Dr Ferran Navarro

  13. Improving the diagnosis of urinary tract infections by the use of enriched media and a 48-hour incubation period

    Article • Journal of Medical Microbiology, June 2024, Society for General Microbiology

    Dr Ferran Navarro

  14. Bacteriuria and phenotypic antimicrobial susceptibility testing in 45 min by point-of-care Sysmex PA-100 System: first clinical evaluation

    Article • European Journal of Clinical Microbiology & Infectious Diseases, June 2024, Springer Science + Business Media

    Dr Ferran Navarro

  15. Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection

    Article • Scientific Reports, June 2024, Springer Science + Business Media

    Dr Ferran Navarro

  16. Comparing the in vitro efficacy of chlorhexidine and povidone-iodine in the prevention of post-surgical endophthalmitis

    Article • Journal of Ophthalmic Inflammation and Infection, May 2024, Springer Science + Business Media

    Dr Ferran Navarro

  17. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain

    Article • Infection, May 2024, Springer Science + Business Media

    Dr Ferran Navarro

  18. Corrigendum: CARB-ES-19 multicenter study of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli from all Spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3

    Article • Frontiers in Microbiology, November 2023, Frontiers

    Dr Ferran Navarro

  19. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

    Article • The Lancet Regional Health - Europe, November 2023, Elsevier

    Dr Ferran Navarro

  20. Recommendations of the Spanish Antibiogram Committee (COESANT) for in vitro susceptibility testing of antimicrobial agents by disk diffusion

    Article • Enfermedades Infecciosas y Microbiología Clínica, November 2023, Elsevier

    Dr Ferran Navarro

  21. Recommendations of the Spanish Antibiogram Committee (COESANT) for in vitro susceptibility testing of antimicrobial agents by disk diffusion

    Article • Enfermedades infecciosas y microbiologia clinica (English ed ), November 2023, Elsevier

    Dr Ferran Navarro

  22. Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports

    Article • Enfermedades infecciosas y microbiologia clinica (English ed ), August 2023, Elsevier

    Dr Ferran Navarro

  23. Detection of cytomegalovirus in bronchoalveolar lavage fluid from immunocompromised patients with pneumonitis by viral culture and DNA quantification

    Article • Journal of Virological Methods, July 2023, Elsevier

    Dr Ferran Navarro

  24. Epidemiology and antimicrobial resistance profile of Neisseria gonorrhoeae in Catalonia, Spain, 2016–2019

    Article • European Journal of Clinical Microbiology & Infectious Diseases, May 2023, Springer Science + Business Media

    Dr Ferran Navarro

  25. Un proyecto de país para la sanidad española del siglo xxi: refundar la centenaria Escuela Nacional de Sanidad

    Article • Gaceta Sanitaria, November 2022, Elsevier

    Dr Ferran Navarro

  26. Host‐associated variability of the cdtABC operon, coding for the cytolethal distending toxin, in Campylobacter jejuni

    Article • Zoonoses and Public Health, September 2022, Wiley

    Dr Ferran Navarro

  27. Viral culture and immunofluorescence for the detection of SARS-CoV-2 infectivity in RT-PCR positive respiratory samples

    Article • Journal of Clinical Virology, July 2022, Elsevier

    Dr Ferran Navarro

  28. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

    Article • Frontiers in Microbiology, June 2022, Frontiers

    Dr Ferran Navarro

  29. A New Variant of the aadE-sat4-aphA-3 Gene Cluster Found in a Conjugative Plasmid from a MDR Campylobacter jejuni Isolate

    Article • Antibiotics, March 2022, MDPI AG

    Dr Ferran Navarro

  30. Corrigendum to “Tetracycline resistance transmission in Campylobacter is promoted at temperatures resembling the avian reservoir” [Vet. Microbiol. (2020) 108652]

    Article • Veterinary Microbiology, March 2022, Elsevier

    Dr Ferran Navarro

  31. Prevalence and seasonality of viral respiratory infections in a temperate climate region: A 24‐year study (1997–2020)

    Article • Influenza and Other Respiratory Viruses, February 2022, Wiley

    Dr Ferran Navarro

  32. Recomendaciones del Comité Español del Antibiograma (COESANT) para la realización de los Informes de Sensibilidad Antibiótica Acumulada

    Article • Enfermedades Infecciosas y Microbiología Clínica, February 2022, Elsevier

    Dr Ferran Navarro

  33. Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2

    Article • mBio, December 2021, ASM Journals

    Dr Ferran Navarro

  34. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Article • Nature Genetics, September 2021, Springer Science + Business Media

    Dr Ferran Navarro

  35. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Article • Nature, June 2021, Springer Science + Business Media

    Dr Ferran Navarro

  36. Epidemiological characteristics and outcomes of COVID-19 cases: mortality inequalities by socio-economic status, Barcelona, Spain, 24 February to 4 May 2020

    Article • Eurosurveillance, May 2021, European Centre for Disease Control and Prevention (ECDC)

    Dr Ferran Navarro

  37. Taxonomic Identification of Different Species of the Genus Aeromonas by Whole-Genome Sequencing and Use of Their Species-Specific β-Lactamases as Phylogenetic Markers

    Article • Antibiotics, March 2021, MDPI AG

    Dr Ferran Navarro

  38. Bacteriophages immunomodulate the response of monocytes

    Article • Experimental Biology and Medicine, February 2021, SAGE Publications

    Dr Ferran Navarro

  39. Whole‐genome analysis to describe a human adenovirus D8 conjunctivitis outbreak in a tertiary hospital

    Article • Journal of Medical Virology, February 2021, Wiley

    Dr Ferran Navarro

  40. Intraoperative Bacterial Contamination and Activity of Different Antimicrobial Prophylaxis Regimens in Primary Knee and Hip Replacement

    Article • Antibiotics, December 2020, MDPI AG

    Dr Ferran Navarro

  41. Do Prosthetic Joint Infections Worsen the Functional Ambulatory Outcome of Patients with Joint Replacements? A Retrospective Matched Cohort Study

    Article • Antibiotics, December 2020, MDPI AG

    Dr Ferran Navarro

  42. Pathogenesis of Staphylococcus epidermidis in prosthetic joint infections: can identification of virulence genes differentiate between infecting and commensal strains?

    Article • Journal of Hospital Infection, July 2020, Elsevier

    Dr Ferran Navarro

  43. Genomic analysis of 40 prophages located in the genomes of 16 carbapenemase-producing clinical strains of Klebsiella pneumoniae

    Article • Microbial Genomics, May 2020, Society for General Microbiology

    lucia blasco, Dr Ferran Navarro, PhD student Laura Fernandez-Garcia

  44. Tetracycline resistance transmission in Campylobacter is promoted at temperatures resembling the avian reservoir

    Article • Veterinary Microbiology, May 2020, Elsevier

    Dr Ferran Navarro

  45. In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens

    Article • Scientific Reports, April 2020, Springer Science + Business Media

    lucia blasco, Dr Ferran Navarro, PhD student Laura Fernandez-Garcia

  46. Unravelling the consequences of the bacteriophages in human samples

    Article • Scientific Reports, April 2020, Springer Science + Business Media

    Dr Ferran Navarro

  47. Comparison of Commensal and Clinical Isolates for Diversity of Plasmids in Escherichia coli and Klebsiella pneumoniae

    Article • Antimicrobial Agents and Chemotherapy, March 2020, ASM Journals

    Dr Ferran Navarro

  48. Differential Distribution of the wlaN and cgtB Genes, Associated with Guillain-Barré Syndrome, in Campylobacter jejuni Isolates from Humans, Broiler Chickens, and Wild Birds

    Article • Microorganisms, February 2020, MDPI AG

    Dr Ferran Navarro

  49. Core/Whole Genome Multilocus Sequence Typing and Core Genome SNP-Based Typing of OXA-48-Producing Klebsiella pneumoniae Clinical Isolates From Spain

    Article • Frontiers in Microbiology, January 2020, Frontiers

    Dr Ferran Navarro

  50. External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteraemia cohort: the prognostic significance of colistin resistance

    Article • International Journal of Antimicrobial Agents, October 2019, Elsevier

    Dr Ferran Navarro

  51. In vitro and in vivo efficacy of the combination of colistin and endolysins against clinical strains of Multi-Drug Resistant (MDR) pathogens

    Article • June 2019, Cold Spring Harbor Laboratory Press

    lucia blasco, Dr Ferran Navarro

  52. Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems

    Article • Enfermedades Infecciosas y Microbiología Clínica, March 2019, Elsevier

    Dr Ferran Navarro

  53. Faecal phageome of healthy individuals: presence of antibiotic resistance genes and variations caused by ciprofloxacin treatment

    Article • Journal of Antimicrobial Chemotherapy, January 2019, Oxford University Press (OUP)

    Dr Ferran Navarro

  54. Population Structure, Antimicrobial Resistance, and Virulence-Associated Genes in Campylobacter jejuni Isolated From Three Ecological Niches: Gastroenteritis Patients, Broilers, and Wild Birds

    Article • Frontiers in Microbiology, August 2018, Frontiers

    Dr Ferran Navarro

  55. Ascitic fluid regulates the local innate immune response of patients with cirrhosis

    Article • Journal of Leukocyte Biology, May 2018, Wiley

    Dr Ferran Navarro

  56. Prevalence of Aminoglycoside-Modifying Enzymes in Escherichia coli and Klebsiella pneumoniae Producing Extended Spectrum β-Lactamases Collected in Two Multicenter Studies in Spain

    Article • Microbial Drug Resistance, May 2018, Mary Ann Liebert Inc

    Dr Ferran Navarro

  57. Molecular characterization of OXA-48 carbapenemase-producing Klebsiella pneumoniae strains after a carbapenem resistance increase in Catalonia

    Article • Enfermedades Infecciosas y Microbiología Clínica, April 2018, Elsevier

    Dr Ferran Navarro

  58. Antibiotic resistance genes in phage particles isolated from human feces and induced from clinical bacterial isolates

    Article • International Journal of Antimicrobial Agents, November 2017, Elsevier

    Dr Ferran Navarro

  59. Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study

    Article • International Journal of Antimicrobial Agents, November 2017, Elsevier

    Dr Ferran Navarro

  60. Prevalence of quinolone resistance mechanisms in Enterobacteriaceae producing acquired AmpC β-lactamases and/or carbapenemases in Spain

    Article • Enfermedades infecciosas y microbiologia clinica (English ed ), October 2017, Elsevier

    Dr Ferran Navarro

  61. Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort

    Article • Clinical Infectious Diseases, August 2017, Oxford University Press (OUP)

    Dr Ferran Navarro

  62. Erratum for Martinez-Castillo et al., “Shiga Toxin 2-Encoding Bacteriophages in Human Fecal Samples from Healthy Individuals”

    Article • Applied and Environmental Microbiology, August 2017, ASM Journals

    Dr Ferran Navarro

  63. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

    Article • The Lancet Infectious Diseases, July 2017, Elsevier

    Dr Ferran Navarro

  64. Increased Antimicrobial Resistance in a Novel CMY-54 AmpC-Type Enzyme with a GluLeu217–218 Insertion in the Ω-Loop

    Article • Microbial Drug Resistance, June 2017, Mary Ann Liebert Inc

    Dr Ferran Navarro

  65. First Description of blaNDM-7 Carried on an IncX4 Plasmid in Escherichia coli ST679 Isolated in Spain

    Article • Microbial Drug Resistance, June 2017, Mary Ann Liebert Inc

    Dr Ferran Navarro

  66. Phages in the Human Body

    Article • Frontiers in Microbiology, April 2017, Frontiers

    Dr Ferran Navarro

  67. Identification of Trypanosoma cruzi Discrete Typing Units (DTUs) in Latin-American migrants in Barcelona (Spain)

    Article • Parasitology International, April 2017, Elsevier

    Dr Ferran Navarro

  68. Characterization of the Genetic Environment of the blaVEB-4 Gene, Associated with a Transposable Region in a Proteus mirabilis Clinical Isolate

    Article • Microbial Drug Resistance, March 2017, Mary Ann Liebert Inc

    Dr Ferran Navarro

  69. The Carbapenemase-Producing Klebsiella pneumoniae Population Is Distinct and More Clonal than the Carbapenem-Susceptible Population

    Article • Antimicrobial Agents and Chemotherapy, January 2017, ASM Journals

    Dr Ferran Navarro

  70. The Identification of Intrinsic Chloramphenicol and Tetracycline Resistance Genes in Members of the Bacillus cereus Group (sensu lato)

    Article • Frontiers in Microbiology, January 2017, Frontiers

    Dr Ferran Navarro

  71. Activity of ceftazidime–avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance

    Article • Enfermedades Infecciosas y Microbiología Clínica, November 2016, Elsevier

    Dr Ferran Navarro

  72. A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae

    Article • Mayo Clinic Proceedings, October 2016, Elsevier

    Dr Ferran Navarro

  73. Bacteriophages in clinical samples can interfere with microbiological diagnostic tools

    Article • Scientific Reports, September 2016, Nature

    Dr Ferran Navarro

  74. Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features

    Article • European Journal of Clinical Microbiology & Infectious Diseases, August 2016, Springer Science + Business Media

    Dr Ferran Navarro, Dr Elena Espejo

  75. Activity of Ceftazidime-Avibactam against Clinical and Isogenic Laboratory Pseudomonas aeruginosa Isolates Expressing Combinations of Most Relevant β-Lactam Resistance Mechanisms

    Article • Antimicrobial Agents and Chemotherapy, August 2016, ASM Journals

    Dr Ferran Navarro

  76. Prevalencia en España de mecanismos de resistencia a quinolonas en enterobacterias productoras de betalactamasas de clase C adquiridas y/o carbapenemasas

    Article • Enfermedades Infecciosas y Microbiología Clínica, June 2016, Elsevier

    Dr Ferran Navarro

  77. Speeding up antimicrobial susceptibility testing

    Article • Enfermedades Infecciosas y Microbiología Clínica, June 2016, Elsevier

    Dr Ferran Navarro

  78. A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae

    Article • Antimicrobial Agents and Chemotherapy, May 2016, ASM Journals

    Dr Ferran Navarro

  79. Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study

    Article • Journal of Antimicrobial Chemotherapy, February 2016, Oxford University Press (OUP)

    Dr Ferran Navarro

  80. Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates

    Article • International Journal of Antimicrobial Agents, January 2016, Elsevier

    Dr JAVIER GARAU, Dr Ferran Navarro, Dr Elena Espejo

  81. Efficacy of the FilmArray blood culture identification panel for direct molecular diagnosis of infectious diseases from samples other than blood

    Article • Journal of Medical Microbiology, December 2015, Society for General Microbiology

    Dr Ferran Navarro, Dr Ferran Sanchez-Reus

  82. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain

    Article • International Journal of Antimicrobial Agents, August 2015, Elsevier

    Dr Ferran Navarro

  83. Benefits and drawbacks of molecular techniques for diagnosis of viral respiratory infections. Experience with two multiplex PCR assays

    Article • Journal of Medical Virology, July 2015, Wiley

    Dr Ferran Navarro

  84. Rates of faecal colonization by carbapenemase-producing Enterobacteriaceae among patients admitted to ICUs in Spain: Table 1.

    Article • Journal of Antimicrobial Chemotherapy, July 2015, Oxford University Press (OUP)

    Dr Ferran Navarro

  85. Mobile Genetic Elements Related to the Diffusion of Plasmid-Mediated AmpC β-Lactamases or Carbapenemases from Enterobacteriaceae: Findings from a Multicenter Study in Spain

    Article • Antimicrobial Agents and Chemotherapy, June 2015, ASM Journals

    Dr Ferran Navarro

  86. Prospective Multicenter Study of Carbapenemase-Producing Enterobacteriaceae from 83 Hospitals in Spain Reveals HighIn VitroSusceptibility to Colistin and Meropenem

    Article • Antimicrobial Agents and Chemotherapy, March 2015, ASM Journals

    Dr Ferran Navarro

  87. Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab

    Article • British Journal of Pharmacology, January 2015, Nature

    Dr Ferran Navarro

  88. Epidemiology and risk factors for infections due to AmpC  -lactamase-producing Escherichia coli

    Article • Journal of Antimicrobial Chemotherapy, December 2014, Oxford University Press (OUP)

    Dr Ferran Navarro, Dr Elena Espejo

  89. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: What should be expected in the future?

    Article • Enfermedades Infecciosas y Microbiología Clínica, December 2014, Elsevier

    Dr Ferran Navarro

  90. Genetic and Kinetic Characterization of the Novel AmpC β-Lactamases DHA-6 and DHA-7

    Article • Antimicrobial Agents and Chemotherapy, August 2014, ASM Journals

    Dr Ferran Navarro

  91. Inhibitor-Resistant TEM- and OXA-1-Producing Escherichia coli Isolates Resistant to Amoxicillin-Clavulanate Are More Clonal and Possess Lower Virulence Gene Content than Susceptible Clinical Isolates

    Article • Antimicrobial Agents and Chemotherapy, April 2014, ASM Journals

    Dr Ferran Navarro

  92. Importancia de los controles de calidad para la detección de la resistencia a antibióticos β-lactámicos en enterobacterias

    Article • Enfermedades Infecciosas y Microbiología Clínica, February 2014, Elsevier

    Dr Ferran Navarro

  93. Antibiotic Resistance Genes in the Bacteriophage DNA Fraction of Human Fecal Samples

    Article • Antimicrobial Agents and Chemotherapy, October 2013, ASM Journals

    Dr Ferran Navarro

  94. Réplica a «Infecciones producidas por Clostridium difficile. Observaciones»

    Article • Enfermedades Infecciosas y Microbiología Clínica, October 2013, Elsevier

    Dr Ferran Navarro

  95. Infecciones producidas por Clostridium difficile. Observaciones

    Article • Enfermedades Infecciosas y Microbiología Clínica, October 2013, Elsevier

    Dr Ferran Navarro

  96. Molecular diagnosis of bloodstream infections with a new dual-priming oligonucleotide-based multiplex PCR assay

    Article • Journal of Medical Microbiology, August 2013, Society for General Microbiology

    Dr Ferran Navarro

  97. Characterization of the New AmpC β-Lactamase FOX-8 Reveals a Single Mutation, Phe313Leu, Located in the R2 Loop That Affects Ceftazidime Hydrolysis

    Article • Antimicrobial Agents and Chemotherapy, July 2013, ASM Journals

    Dr Ferran Navarro

  98. Shiga Toxin 2-Encoding Bacteriophages in Human Fecal Samples from Healthy Individuals

    Article • Applied and Environmental Microbiology, June 2013, ASM Journals

    Dr Ferran Navarro

  99. Infecciones producidas por Clostridium difficile

    Article • Enfermedades Infecciosas y Microbiología Clínica, April 2013, Elsevier

    Dr Ferran Navarro

  100. Characterization of Aminoglycoside-Modifying Enzymes inEnterobacteriaceaeClinical Strains and Characterization of the Plasmids Implicated in Their Diffusion

    Article • Microbial Drug Resistance, April 2013, Mary Ann Liebert Inc

    Dr Ferran Navarro

  101. Epidemiology of Clostridium difficile Infection and Risk Factors for Unfavorable Clinical Outcomes: Results of a Hospital-Based Study in Barcelona, Spain

    Article • Journal of Clinical Microbiology, February 2013, ASM Journals

    Dr Ferran Navarro

  102. Outbreak of Pseudomonas fluorescens bloodstream infection in a coronary care unit

    Article • Journal of Hospital Infection, December 2012, Elsevier

    Dr Ferran Navarro

  103. Erratum to: Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain

    Article • European Journal of Clinical Microbiology & Infectious Diseases, October 2012, Springer Science + Business Media

    Dr Ferran Navarro

  104. Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain

    Article • European Journal of Clinical Microbiology & Infectious Diseases, September 2012, Springer Science + Business Media

    Dr Ferran Navarro

  105. Characterization of a Novel IMP-28 Metallo-β-Lactamase from a Spanish Klebsiella oxytoca Clinical Isolate

    Article • Antimicrobial Agents and Chemotherapy, June 2012, ASM Journals

    Dr Ferran Navarro

  106. Spanish Multicenter Study of the Epidemiology and Mechanisms of Amoxicillin-Clavulanate Resistance in Escherichia coli

    Article • Antimicrobial Agents and Chemotherapy, April 2012, ASM Journals

    Dr Ferran Navarro

  107. Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases

    Article • Journal of Infection, February 2012, Elsevier

    Dr Ferran Navarro

  108. Utilización de diferentes técnicas de biología molecular integradas en un algoritmo de identificación de micobacterias no tuberculosas

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2012, Elsevier

    Dr Ferran Navarro

  109. Plasmid typing and genetic context of AmpC  -lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: findings from a Spanish hospital 1999-2007

    Article • Journal of Antimicrobial Chemotherapy, October 2011, Oxford University Press (OUP)

    Dr Ferran Navarro

  110. Association of blaDHA-1 and qnrB genes carried by broad-host-range plasmids among isolates of Enterobacteriaceae at a Spanish hospital

    Article • Clinical Microbiology and Infection, October 2011, Elsevier

    Dr Ferran Navarro

  111. Detección fenotípica de mecanismos de resistencia en microorganismos gramnegativos

    Article • Enfermedades Infecciosas y Microbiología Clínica, August 2011, Elsevier

    Dr Ferran Navarro

  112. Prevalence of SXT/R391-like integrative and conjugative elements carrying blaCMY-2 in Proteus mirabilis

    Article • Journal of Antimicrobial Chemotherapy, July 2011, Oxford University Press (OUP)

    Dr Ferran Navarro

  113. Multiclonal epidemic of Klebsiella pneumoniae isolates producing DHA-1 in a Spanish hospital

    Article • Clinical Microbiology and Infection, July 2011, Elsevier

    Dr Ferran Navarro

  114. Intra- and inter-species spread of carbapenemase genes in a non-hospitalized patient

    Article • European Journal of Clinical Microbiology & Infectious Diseases, April 2011, Springer Science + Business Media

    Dr Ferran Navarro

  115. Diagnostic accuracy of a 16S ribosomal DNA gene-based molecular technique (RT-PCR, microarray, and sequencing) for bacterial meningitis, early-onset neonatal sepsis, and spontaneous bacterial peritonitis

    Article • Diagnostic Microbiology and Infectious Disease, February 2011, Elsevier

    Dr Ferran Navarro

  116. Bacterial DNA in the diagnosis of spontaneous bacterial peritonitis

    Article • Alimentary Pharmacology & Therapeutics, November 2010, Wiley

    Dr Carlos Guarner-Argente, Dr Ferran Navarro

  117. Lectura interpretada del antibiograma de enterobacterias

    Article • Enfermedades Infecciosas y Microbiología Clínica, November 2010, Elsevier

    Dr Ferran Navarro

  118. Corrigendum to “Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2” [Int. J. Antimicrob. Agents 34 (2009) 173–176]

    Article • International Journal of Antimicrobial Agents, November 2010, Elsevier

    Dr Ferran Navarro

  119. Fe de errores de «Caracterización y epidemiología molecular de betalactamasas de espectro extendido en Escherichia coli y Klebsiella pneumoniae en once hospitales españoles (2004)»

    Article • Enfermedades Infecciosas y Microbiología Clínica, October 2010, Elsevier

    Dr Ferran Navarro

  120. Characterisation of the CTX-M-15-encoding gene in Klebsiella pneumoniae strains from the Barcelona metropolitan area: plasmid diversity and chromosomal integration

    Article • International Journal of Antimicrobial Agents, July 2010, Elsevier

    Dr Ferran Navarro

  121. Plasmid-mediated QnrS2 determinant in an Aeromonas caviae isolate recovered from a patient with diarrhoea

    Article • Clinical Microbiology and Infection, July 2010, Elsevier

    Dr Ferran Navarro

  122. Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain

    Article • Journal of Antimicrobial Chemotherapy, June 2010, Oxford University Press (OUP)

    Dr Ferran Navarro

  123. Prevalence of acquired AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007

    Article • Clinical Microbiology and Infection, May 2010, Elsevier

    Dr Ferran Navarro

  124. In vivo transmission of a plasmid coharbouring blaDHA-1 and qnrB genes between Escherichia coli and Serratia marcescens

    Article • FEMS Microbiology Letters, April 2010, Oxford University Press (OUP)

    Dr Ferran Navarro

  125. 197 BACTERIAL DNA DETECTION BY REAL-TIME PCR AND 16s RDNA GENE SEQUENCING IN SPONTANEOUS BACTERIAL PERITONITIS

    Article • Journal of Hepatology, April 2010, Elsevier

    Dr Carlos Guarner-Argente, Dr Ferran Navarro

  126. Isolation and Characterization of Potentially Pathogenic Antimicrobial-Resistant Escherichia coli Strains from Chicken and Pig Farms in Spain

    Article • Applied and Environmental Microbiology, March 2010, ASM Journals

    Dr Ferran Navarro

  127. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues

    Article • Clinical Microbiology and Infection, February 2010, Elsevier

    Dr Ferran Navarro

  128. Spread of plasmids containing the blaVIM-1 and blaCTX-M genes and the qnr determinant in Enterobacter cloacae, Klebsiella pneumoniae and Klebsiella oxytoca isolates

    Article • Journal of Antimicrobial Chemotherapy, January 2010, Oxford University Press (OUP)

    Dr Ferran Navarro, Concepcion Segura

  129. Escherichia coli y Klebsiella pneumoniae productoras de betalactamasas de espectro extendido en hospitales españoles: segundo estudio multicéntrico (proyecto GEIH-BLEE 2006)

    Article • Enfermedades Infecciosas y Microbiología Clínica, November 2009, Elsevier

    Dr Ferran Navarro

  130. Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2

    Article • International Journal of Antimicrobial Agents, August 2009, Elsevier

    Dr Ferran Navarro

  131. Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain

    Article • Journal of Antimicrobial Chemotherapy, July 2009, Oxford University Press (OUP)

    Dr Ferran Navarro

  132. Ability of the new VITEK® 2Neisseria-Haemophilus card for the identification of fastidious organisms

    Article • Annals of Microbiology, December 2008, Springer Science + Business Media

    Dr Ferran Sanchez-Reus, Dr Ferran Navarro

  133. Detection and reporting β-lactam resistance phenotypes in Escherichia coli and Klebsiella pneumoniae: a multicenter proficiency study in Spain

    Article • Diagnostic Microbiology and Infectious Disease, November 2008, Elsevier

    Dr Ferran Navarro

  134. FE DE ERRORES

    Article • Enfermedades Infecciosas y Microbiología Clínica, November 2008, Elsevier

    Dr Ferran Navarro

  135. Characterization of plasmids encoding blaESBL and surrounding genes in Spanish clinical isolates of Escherichia coli and Klebsiella pneumoniae

    Article • Journal of Antimicrobial Chemotherapy, October 2008, Oxford University Press (OUP)

    Dr Ferran Navarro

  136. Caracterización y epidemiología molecular de betalactamasas de espectro extendido en Escherichia coli y Klebsiella pneumoniae en once hospitales españoles (2004)

    Article • Enfermedades Infecciosas y Microbiología Clínica, September 2008, Elsevier

    Dr Ferran Navarro, Professor Teresa M. Coque

  137. Dissemination of extended-spectrum  -lactamase-producing bacteria: the food-borne outbreak lesson

    Article • Journal of Antimicrobial Chemotherapy, March 2008, Oxford University Press (OUP)

    Dr Ferran Navarro

  138. Increase in  -lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type  -lactamases

    Article • Journal of Antimicrobial Chemotherapy, March 2008, Oxford University Press (OUP)

    Dr Ferran Navarro

  139. Lymphadenopathy Caused by Mycobacterium colombiense

    Article • Journal of Clinical Microbiology, February 2008, ASM Journals

    Dr Ferran Navarro

  140. Characterisation of plasmids encoding extended-spectrum β-lactamase and CMY-2 in Escherichia coli isolated from animal farms

    Article • International Journal of Antimicrobial Agents, January 2008, Elsevier

    Dr Ferran Navarro

  141. Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals

    Article • Antimicrobial Agents and Chemotherapy, October 2007, ASM Journals

    Dr Ferran Navarro

  142. Evidence for convergent evolution of CTX-M-14 ESBL inEscherichia coliand its prevalence

    Article • FEMS Microbiology Letters, August 2007, Oxford University Press (OUP)

    Dr Ferran Navarro

  143. Recomendaciones para la selección de antimicrobianos en el estudio de la sensibilidad in vitro con sistemas automáticos y semiautomáticos

    Article • Enfermedades Infecciosas y Microbiología Clínica, July 2007, Elsevier

    Professor Fernando Baquero, Dr Ferran Navarro

  144. Acquisition and diffusion of blaCTX-M-9 gene by R478-IncHI2 derivative plasmids

    Article • FEMS Microbiology Letters, June 2007, Oxford University Press (OUP)

    Dr Ferran Navarro

  145. Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues

    Article • International Journal of Antimicrobial Agents, April 2007, Elsevier

    Dr Francesco Luzzaro, Dr Ferran Navarro, Francesco Luzzaro

  146. Relevancia de la detección de los fenómenos de sinergias y antagonismos entre antimicrobianos en los sistemas automatizados de lectura de antibiogramas

    Article • Enfermedades Infecciosas y Microbiología Clínica, February 2007, Elsevier

    Dr Ferran Navarro

  147. ESBL- and plasmidic class C β-lactamase-producing E. coli strains isolated from poultry, pig and rabbit farms

    Article • Veterinary Microbiology, December 2006, Elsevier

    Dr Ferran Navarro

  148. Streptococcus agalactiae altamente resistente a fluoroquinolonas

    Article • Enfermedades Infecciosas y Microbiología Clínica, November 2006, Elsevier

    Dr Ferran Navarro

  149. Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain

    Article • Journal of Medical Microbiology, August 2006, Society for General Microbiology

    Dr Ferran Navarro

  150. A simple phenotypic method for differentiation between acquired and chromosomal AmpC β-lactamases in Escherichia coli

    Article • Enfermedades Infecciosas y Microbiología Clínica, July 2006, Elsevier

    Dr Ferran Navarro

  151. Extended-spectrum  -lactamase-producing Enterobacteriaceae in different environments (humans, food, animal farms and sewage)

    Article • Journal of Antimicrobial Chemotherapy, May 2006, Oxford University Press (OUP)

    Dr Ferran Navarro

  152. Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays

    Article • Journal of Antimicrobial Chemotherapy, March 2006, Oxford University Press (OUP)

    Dr Ferran Navarro

  153. Surveillance of extended-spectrum β-lactamases from clinical samples and faecal carriers in Barcelona, Spain

    Article • Journal of Antimicrobial Chemotherapy, October 2005, Oxford University Press (OUP)

    Dr Ferran Navarro

  154. Characterization of the highly variable region surrounding the blaCTX-M-9 gene in non-related Escherichia coli from Barcelona

    Article • Journal of Antimicrobial Chemotherapy, September 2005, Oxford University Press (OUP)

    Dr Ferran Navarro

  155. Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain

    Article • Clinical Microbiology and Infection, September 2005, Elsevier

    Dr Ferran Navarro, Dr Ferran Sanchez-Reus

  156. First Detection of a Carbapenem-Hydrolyzing Metalloenzyme in Two Enterobacteriaceae Isolates in Spain

    Article • Antimicrobial Agents and Chemotherapy, August 2005, ASM Journals

    Dr Ferran Navarro

  157. Escherichia coli Producing an ACC-1 Class C β-Lactamase Isolated in Barcelona, Spain

    Article • Antimicrobial Agents and Chemotherapy, February 2005, ASM Journals

    Dr Ferran Navarro

  158. Bacteriophages and Diffusion of β-lactamase Genes

    Article • Emerging Infectious Diseases, June 2004, Centers for Disease Control and Prevention (CDC)

    Dr Ferran Navarro

  159. In Vitro Activity of the Active Metabolite of Prulifloxacin (AF 3013) Compared with Six Other Fluoroquinolones

    Article • European Journal of Clinical Microbiology & Infectious Diseases, May 2004, Springer Science + Business Media

    Dr Ferran Navarro

  160. Resistencia a quinolonas y betalactámicos en Salmonella enterica, y su relación con mutaciones en las topoisomerasas, alteraciones en la permeabilidad celular y expresión de un mecanismo de expulsión activa

    Article • Enfermedades Infecciosas y Microbiología Clínica, April 2004, Elsevier

    Dr Ferran Navarro

  161. Resistencia a quinolonas y betalactámicos en Salmonella enterica, y su relación con mutaciones en las topoisomerasas, alteraciones en la permeabilidad celular y expresión de un mecanismo de expulsión activa

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2004, Elsevier

    Dr Ferran Navarro

  162. Cephalosporin-resistantEscherichia coliamong Summer Camp Attendees with Salmonellosis

    Article • Emerging Infectious Diseases, October 2003, Centers for Disease Control and Prevention (CDC)

    Dr Ferran Navarro

  163. Community Transmission of Extended-Spectrum ß-Lactamase

    Article • Emerging Infectious Diseases, August 2003, Centers for Disease Control and Prevention (CDC)

    Dr Ferran Navarro

  164. Are There Regional Variations in the Diagnosis, Surveillance, and Control of Methicillin-Resistant Staphylococcus aureus?

    Article • Infection Control, May 2003, Cambridge University Press

    Dr Ferran Navarro

  165. Prevalence of Clinical Isolates of Escherichia coli Producing Inhibitor-Resistant β-Lactamases at a University Hospital in Barcelona, Spain, over a 3-Year Period

    Article • Antimicrobial Agents and Chemotherapy, December 2002, ASM Journals

    Dr Ferran Navarro

  166. Novel Complex sul1-Type Integron in Escherichia coli Carrying blaCTX-M-9

    Article • Antimicrobial Agents and Chemotherapy, August 2002, ASM Journals

    Dr Ferran Navarro

  167. beta-Lactamases involved in resistance to broad-spectrum cephalosporins in Escherichia coli and Klebsiella spp. clinical isolates collected between 1994 and 1996, in Barcelona (Spain)

    Article • Journal of Antimicrobial Chemotherapy, June 2002, Oxford University Press (OUP)

    Dr Ferran Navarro

  168. Update on CTX-M-type β-lactamases

    Article • Reviews in Medical Microbiology, April 2002, Wolters Kluwer Health

    Dr Ferran Navarro

  169. In Vitro Activity of the Active Metabolite of Prulifloxacin (AF 3013) Compared with Six Other Fluoroquinolones

    Article • European Journal of Clinical Microbiology & Infectious Diseases, April 2002, Springer Science + Business Media

    Dr Ferran Navarro

  170. Lectura interpretada del antibiograma de enterobacterias

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2002, Elsevier

    Dr Ferran Navarro

  171. Virus de la hepatitis C y diabetes mellitus tipo 2, ¿existe relación?

    Article • Enfermedades Infecciosas y Microbiología Clínica, January 2002, Elsevier

    Dr Ferran Navarro

  172. CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000)

    Article • Journal of Antimicrobial Chemotherapy, September 2001, Oxford University Press (OUP)

    Dr Ferran Navarro

  173. Quinolone Resistance-Determining Regions of gyrA andparC in Pasteurella multocida Strains with Different Levels of Nalidixic Acid Resistance

    Article • Antimicrobial Agents and Chemotherapy, March 2001, ASM Journals

    Dr Ferran Navarro

  174. Salmonella enterica Serovar Virchow with CTX-M-Like β-Lactamase in Spain

    Article • Journal of Clinical Microbiology, December 2000, ASM Journals

    Dr Ferran Navarro

  175. Cloning and Sequence of the Gene Encoding a Novel Cefotaxime-Hydrolyzing β-Lactamase (CTX-M-9) from Escherichia coli in Spain

    Article • Antimicrobial Agents and Chemotherapy, July 2000, ASM Journals

    Dr Ferran Navarro

  176. Antibiotic Resistance Trends in Enteropathogenic Bacteria Isolated in 1985–1987 and 1995–1998 in Barcelona

    Article • Antimicrobial Agents and Chemotherapy, May 2000, ASM Journals

    Dr Ferran Navarro

  177. Resistance of Salmonella and Campylobacter Species to Antimicrobial Agents

    Article • European Journal of Clinical Microbiology & Infectious Diseases, May 1999, Springer Science + Business Media

    Dr Ferran Navarro

  178. Correlation between serotype and in-vitro antibiotic susceptibility of pneumococci isolated in Saudi Arabia

    Article • Journal of Antimicrobial Chemotherapy, January 1999, Oxford University Press (OUP)

    Dr Ferran Navarro, Dr Ferran Sanchez-Reus

  179. Increase in Quinolone Resistance in aHaemophilus influenzae Strain Isolated from a Patient with Recurrent Respiratory Infections Treated with Ofloxacin

    Article • Antimicrobial Agents and Chemotherapy, January 1999, ASM Journals

    Dr Ferran Navarro

  180. Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction

    Article • Journal of Antimicrobial Chemotherapy, October 1998, Oxford University Press (OUP)

    Dr Ferran Navarro

  181. Epidemiology of an Unusually Prolonged Outbreak of Typhoid Fever in Terrassa, Spain

    Article • Clinical Infectious Diseases, March 1997, Oxford University Press (OUP)

    Dr Ferran Navarro

  182. Escherichia coli bacteraemia. Serotype O15:K52:H1 as a urinary pathogen

    Article • Journal of Hospital Infection, November 1996, Elsevier

    Dr Ferran Navarro, Dr JAVIER GARAU

  183. Molecular typing of Salmonella enterica serovar typhi

    Article • Journal of Clinical Microbiology, November 1996, ASM Journals

    Dr Ferran Navarro

  184. Emergence of different resistance mechanisms inPseudomonas aeruginosa in a patient treated with imipenem

    Article • European Journal of Clinical Microbiology & Infectious Diseases, August 1995, Springer Science + Business Media

    Dr Ferran Navarro, Dr Ferran Sanchez-Reus

  185. Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens.

    Article • Antimicrobial Agents and Chemotherapy, August 1994, ASM Journals

    Dr Ferran Navarro

  186. In-vitro activity of E-4695, a new fluoronaphthyridine antimicrobial agent

    Article • Journal of Antimicrobial Chemotherapy, January 1994, Oxford University Press (OUP)

    Dr Ferran Navarro

  187. Campylobacter Species: Identification and Resistance to Quinolones

    Article • Clinical Infectious Diseases, October 1993, Oxford University Press (OUP)

    Dr Ferran Navarro

  188. Increased resistance of enteropathogens to fluoroquinolones in Barcelona, Spain

    Article • European Journal of Clinical Microbiology & Infectious Diseases, August 1993, Springer Science + Business Media

    Dr Ferran Navarro

  189. Neisseriaceae isolated from unusual sites

    Article • Clinical Microbiology Newsletter, June 1993, Elsevier

    Dr Ferran Sanchez-Reus, Dr Ferran Navarro

  190. Prospective study of bacteremia during transesophageal echocardiography

    Article • American Heart Journal, May 1993, Elsevier

    Dr Ferran Navarro

  191. Increased resistance to quinolone in Catalonia, Spain

    Article • Diagnostic Microbiology and Infectious Disease, February 1993, Elsevier

    Dr Ferran Navarro

  192. Campylobacter spp antibiotic susceptibility

    Article • Journal of Antimicrobial Chemotherapy, January 1993, Oxford University Press (OUP)

    Dr Ferran Navarro